LifeSci Acquisition Corp

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors: LifeSci Investments
IPO Size: $50M
Underwriters: Chardan Capital Markets
B. Riley
Focus: Healthcare
SEC Filings: 1796129
Public Embarc Page: https://embarc.com/capital/spac/1796129/LSAC/lifesci-acquisition
IPO Ticker: LSAC

SPAC Leadership

Information on the SPAC leadership.

Chief Executive OfficerAndrew McDonald
Chief Operating OfficerMichael Rice
Chief Financial OfficerDavid Dobkin
DirectorJonas Grossman
DirectorKarin Walker
DirectorBarry Dennis
DirectorJohn Ziegler, M.D.
DirectorBrian Schwartz, M.D.

Target Information

Information on the SPAC target for merger.

Company: Vincera Pharma
New Ticker: VINC VINCW
Description: Vincera Pharma is a "biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics."